News Briefs

These are glimpses into the work we do, the things we care about, and the milestones we’re working towards.

Our Commitment to the Most Common Adult Leukemia

Learn more about the symptoms and treatment of chronic lymphocytic leukemia (CLL).

AbbVie Honored with Global Citizen Award

International Medical Corps celebrates its partnership with AbbVie that brings medical, psycho-social and disaster support to vulnerable populations.

AbbVie Proud of Our National Merit Scholars

We are pleased to participate in the National Merit Scholarship Program to recognize outstanding high school students of our employees' families.

Five Things to Know About Lung Cancer

November is Lung Cancer Awareness Month and as the second most common cancer in both men and women, many people have heard of it, but may not know important facts.

Survey Sheds Light on Under-Recognized Digestive Condition, EPI

While digestive conditions affect approximately 60 to 70 million in the U.S., many don’t recognize it. A new survey examines misperceptions in gastrointestinal health. 
 

AbbVie’s Rova-T Wins ‘Most Promising Clinical Candidate’ Award

AbbVie’s Rova-T Wins ‘Most Promising Clinical Candidate’ Award award at World Antibody Drug Conjugate Summit.

AbbVie Repeats as a Working Mother “100 Best Company”

For the fourth consecutive year, AbbVie has made Working Mother magazine’s list of “100 Best Companies.”
 

14 Ways Your Donation Helps Real People

When you donate to a worthy cause, you want to know exactly how that contribution helps real people.
 

AbbVie Leads Industry in Dow Jones Sustainability World Index

AbbVie is the industry leader in Dow Jones Sustainability World Index with the highest score of 34 biotechnology companies.

Second Quarter 2016 Financial Results

Double-digit revenue and adjusted EPS growth for the 6th consecutive quarter